Lipids and lipid compositions for the delivery of active agents
申请人:Novartis AG
公开号:US10426737B2
公开(公告)日:2019-10-01
This invention provides for a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R1-R3, n, p, L1 and L2 are defined herein. The compounds of formula (I) and pharmaceutically acceptable salts thereof are cationic lipids useful in the delivery of biologically active agents to cells and tissues.
LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS
申请人:Novartis AG
公开号:EP3083579A1
公开(公告)日:2016-10-26
Lipids and Lipid Compositions for the Delivery of Active Agents
申请人:Brito Luis
公开号:US20160317458A1
公开(公告)日:2016-11-03
This invention provides for a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R
1
-R
3
, n, p, L
1
and L
2
are defined herein. The compounds of formula (I) and pharmaceutically acceptable salts thereof are cationic lipids useful in the delivery of biologically active agents to cells and tissues.
[EN] LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS<br/>[FR] LIPIDES ET COMPOSITIONS LIPIDIQUES DESTINÉS À LA LIBÉRATION D'AGENTS ACTIFS
申请人:NOVARTIS AG
公开号:WO2015095346A1
公开(公告)日:2015-06-25
This invention provides for a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R1-R3, n, p, L1 and L2 are defined herein. The compounds of formula (I) and pharmaceutically acceptable salts thereof are cationic lipids useful in the delivery of biologically active agents to cells and tissues.